Lion’s Mane Ingredient Targets Standardized Erinacine A

Cognitive health remains one of the most active categories in the dietary supplement industry, prompting manufacturers to seek ingredients with clearly defined specifications, consistent production methods, and growing bodies of scientific research.

A newly introduced lion’s mane mycelium ingredient, ErinaPrime,¹ is entering the market with a focus on standardized erinacine A content and analytical verification.² The ingredient is positioned for formulators developing products in the cognitive health category and looking for alternatives to traditional mycelium fermented grain ingredients.

“Nammex has historically focused on organic mushroom extract powders because most mycelium ingredients on the market are mycelium fermented grain products with chemical profiles much closer to the grain substrate than to pure mycelium,” said Skye Chilton, CEO of Nammex. “ErinaPrime is fundamentally different. It is 100% pure lion’s mane mycelium standardized to 1% Erinacine A.”

What Is Driving Interest in Erinacine A?

Erinacine A is a naturally occurring compound found in lion’s mane mycelium that has become a focus of research related to neurocognitive health. As consumer interest in brain health continues to grow, manufacturers are increasingly evaluating ingredients that can provide measurable and verified levels of bioactive compounds.

The introduction of a standardized ingredient reflects a broader trend within the supplement industry toward greater transparency around ingredient composition and potency. For formulators, the ability to work with ingredients that have clearly defined specifications can help support consistency across product development and manufacturing processes.

How Is the Ingredient Produced?

According to the company, the ingredient is produced through a submerged liquid fermentation process rather than grain-based fermentation systems commonly used in portions of the mushroom ingredient market.² Following cultivation, the mycelium is freeze-dried to preserve its natural biochemical composition without the use of extraction solvents.

“Protecting the integrity of the erinacines is paramount throughout the entire process,” added Chilton. “Mycelium is fragile, and consistently producing meaningful levels of erinacine A at commercial scale requires specialized expertise in strain optimization, liquid culture fermentation, analytical verification, and quality assurance. Every stage of production is focused on preserving the biochemical composition and consistency of the mycelium.”

The ingredient is standardized to contain 1% erinacine A, equivalent to 10 milligrams per gram, with potency verified through testing conducted by an independent accredited laboratory.

Why Does Standardization Matter for Manufacturers?

Ingredient variability remains a challenge across many botanical and mushroom categories. Differences in cultivation methods, processing techniques, and testing methodologies can affect the composition of finished ingredients and create formulation challenges for manufacturers.

The launch highlights growing industry interest in analytical verification and quality control systems designed to improve consistency. According to the announcement, development of the ingredient involved investments in specialized production infrastructure, reference standards, and analytical methods focused specifically on erinacine verification.

“There’s no shortcut to bringing a genuinely novel ingredient like ErinaPrime to market,” noted Paul Eftang, CEO of Novelara. “We spent the better part of a decade building the scientific infrastructure to make this possible; a mushroom research facility, a reference standard manufacturing lab, and new analytical methods developed specifically to standardize erinacine A.”

What Are the Next Steps for the Category?

The ingredient is supported by an ongoing research program that includes completed human studies and additional investigations currently underway. As interest in cognitive health continues to expand, further research may help clarify the role of standardized lion’s mane mycelium ingredients within the broader brain health category.

For manufacturers, the emergence of ingredients with defined bioactive content may contribute to a continued shift toward more standardized and research-supported approaches to mushroom-based product development.

“We are partnering with Nammex to extend the reach of ErinaPrime and help push the mushroom ingredient category toward higher-quality, science-founded ingredients,” Eftang added.

References

1. What is ErinaPrime. Novelera. Accessed June 2, 2026. Press release provided via email.

2. Nammex introduces ErinaPrime pure lion’s mane mycelium ingredient entirely free of grain or fillers through exclusive partnership with Novelara. Nammex. June 1, 2026. Accessed June 2, 2026. Press release provided via email.